Tomosynthesis cuts interval breast cancers by a quarter in major screening trial
The TOSYMA trial of nearly 100,000 women found that digital breast tomosynthesis reduced invasive interval breast cancers by 29 percent ...
The TOSYMA trial of nearly 100,000 women found that digital breast tomosynthesis reduced invasive interval breast cancers by 29 percent ...
A modelling study of England's 2019/2020 screening cohort estimates that replacing paternal blood testing with NIPT in the sickle cell ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.